Study Phase 4

A Multi-center Randomized Parallel Group Study Evaluating Treatment Outcomes of Concerta (Extended Release Methylphenidate) and Strattera (Atomoxetine) in Children With Attention-deficit/Hyperactivity Disorder

Trial Information

Generic NameMethylphenidate HClProduct NameCONCERTA®Therapeutic AreaNervous SystemProduct ClassPsychoanalepticsPharmacological SubgroupPsychostimulants, Agents Used for ADHD and NootropicsChemical SubgroupCentrally Acting SympathomimeticsCondition StudiedAttention Deficit Hyperactivity Disorder
Sponsor Protocol NumberCR008329 (12-101)Enrollment1323Data PartnerJohnson & Johnson% Female25.7%Mean/Median Age (Years)8.9% White76.7%

Supporting Documentation

  • Collected Datasets Available
  • Data Definition Specification Available
  • Protocol with Amendments Available
  • Clinical Study Report Available

Approved Data Requests Associated with this Trial

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.